 Connection
Jason Glanz to Prospective Studies
This is a "connection" page, showing publications Jason Glanz has written about Prospective Studies.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.079 |
|
|
|
-
Palmer-Toy DE, Yan R, Narwaney KJ, Legaspi A, Aragones M, Lam JA, Chang JM, Portugal C, Bruxvoort KJ, Glanz JM, Binswanger IA. SARS-CoV-2 humoral immunity is associated with elevated hemoglobin A1c. Lab Med. 2026 Jan 07; 57(1).
Score: 0.024
-
Zerbo O, Bartlett J, Fireman B, Lewis N, Goddard K, Dooling K, Duffy J, Glanz J, Naleway A, Donahue JG, Klein NP. Effectiveness of Recombinant Zoster Vaccine Against Herpes Zoster in a Real-World Setting. Ann Intern Med. 2024 02; 177(2):189-195.
Score: 0.021
-
Daley MF, Clarke CL, Glanz JM, Xu S, Hambidge SJ, Donahue JG, Nordin JD, Klein NP, Jacobsen SJ, Naleway AL, Jackson ML, Lee G, Duffy J, Weintraub E. The safety of live attenuated influenza vaccine in children and adolescents 2 through 17 years of age: A Vaccine Safety Datalink study. Pharmacoepidemiol Drug Saf. 2018 01; 27(1):59-68.
Score: 0.014
-
Daley MF, Yih WK, Glanz JM, Hambidge SJ, Narwaney KJ, Yin R, Li L, Nelson JC, Nordin JD, Klein NP, Jacobsen SJ, Weintraub E. Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine. Vaccine. 2014 May 23; 32(25):3019-24.
Score: 0.011
-
Shui IM, Baggs J, Patel M, Parashar UD, Rett M, Belongia EA, Hambidge SJ, Glanz JM, Klein NP, Weintraub E. Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants. JAMA. 2012 Feb 08; 307(6):598-604.
Score: 0.009
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|